Cole Eye Institute Retina Summit

Release Date: June 29, 2016

Expiration Date: June 29, 2017

Statement of Need/Program Overview
The aim of the Cole Eye Institute Retina Summit is to provide retina specialists with a comprehensive medical and surgical update in new advancements in retina covering a wide variety of topics. In particular, imaging has become critical to enhancing the accuracy of diagnosis and supporting improved treatment outcomes for diseases of the retina and vitreoretinal interface. Noninvasive high-resolution imaging with optical coherence tomography (OCT) has especially transformed the field of retinal medicine. In addition, the introduction of nonsurgical pharmacologic treatment options and the progressive improvement of existing surgical approaches have expanded the therapeutic armamentarium for retinal diseases such as macular degeneration or edema. Increased options may also translate to greater chances of treatment success for patients who are resistant to standard first-line approaches.

Content Source
This continuing education (CE) activity captures the Cole Eye Institute Retina Summit live event originally presented live on April 29, 2016 in Seattle, Washington, prior to the Association for Research in Vision and Ophthalmology.

Target Audience
The Cole Eye Institute Retina Summit is for retina specialists, comprehensive ophthalmologists, retina fellows and healthcare providers who are interested in applying the most recent advancements in the retinal medicine field, including emerging techniques for imaging and treating retinal and vitreoretinal diseases.

Educational Objectives
After completing this activity, the participant should be better able to:

• To assess treatment strategies and outcomes, including management options for patients with diabetic macular edema (DME)
• To identify therapeutic options for the management of treatment-resistant age-related macular degeneration (AMD)
• To integrate into clinical practice available technologies for early detection, disease, typing, and disease monitoring
• To optimize the timing of patient assessment and care in patients with vitreoretinal interface disease
• To adopt best practices in surgery and postoperative care of patients with retinal disease
• To summarize recent clinical trial data and what we’ve learned for retinal diseases

Faculty and Affiliation
David S. Boyer, MD: Retina-Vitreous Associated Medical Group, Los Angeles, CA
Justis P. Ehlers, MD: Cole Eye Institute, Cleveland Clinic, Cleveland, OH
Peter K. Kaiser, MD: Cole Eye Institute, Cleveland Clinic, Cleveland, OH
John W. Kitchens, MD: Retina Associates of Kentucky, Lexington, KY
Baruch D. Kuppermann, MD, PhD: Gavin Herbert Eye Institute, Irvine, CA
Daniel F. Martin, MD: Cole Eye Institute, Cleveland Clinic, Cleveland, OH
Darius M. Moshfeghi, MD: Stanford University Medical Center, Palo Alto, CA
Rishi P. Singh, MD: Cole Eye Institute, Cleveland Clinic, Cleveland, OH
Sunil K. Srivastava, MD Cole Eye Institute, Cleveland Clinic, Cleveland, OH

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and MCME Global.  Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 5.5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Term of Offering
This activity was released on June 29, 2016 and is valid for one year. Requests for credits must be made no later than June 29, 2017.

Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com.

Instructions to Receive Credit
If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation before June 29, 2017. Upon successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available within 4-6 weeks, by email.  Should you need your certificate sooner, please email Laura Gilsdorf directly at lgilsdorf@globaleducationgroup.com with your request.  Post-tests will be graded manually upon submission.  If you did not pass, an email will be sent to you, requesting that you complete the post-test a second time for a passing score.  If you fail to pass on the second attempt, credits will not be awarded. 

Please note that this activity is for a total of 5 credit hours, and credits may only be claimed once. If you wish to receive the full 5 hours of CME, but have not viewed all the content, please close this page and revisit the content prior to submitting an application for credits. If you have only viewed a portion of the content, and only wish to claim that portion, please continue, but note that you will not be able to obtain additional credit hours for this activity in the future.

System Requirements
PC Microsoft Windows 2000 SE or above.
Flash Player Plugin (v7.0.1.9 or greater)
Internet Explorer (v5.5 or greater), or Firefox
Adobe Acrobat Reader*
MAC
MAC OS 10.2.8
Flash Player Plugin (v7.0.1.9 or greater)
Safari
Adobe Acrobat Reader*
Internet Explorer is not supported on the Macintosh.
*Required to view printable (PDF) version of the lesson.

Fee Information& Refund/Cancellation Policy
There is no fee for this educational activity.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and MCME Global do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Grantor Statement
This activity is supported by an educational grant from Alcon, Genentech, Inc. and Regeneron Pharmaceuticals, Inc.

This activity is jointly provided by Global Education Group and MCME Global.

AMD

1. Dry AMD: Lessons From AREDS/AREDS2 - Baruch D. Kuppermann, MD, PhD
2. Combined Therapy in Neovascular AMD Now and in the Future - Darius M. Moshfeghi, MD
3. Sustained Delivery Options for Neovascular AMD - David S. Boyer, MD
4. Case Panel Discussion: AMD - All faculty (Moderator: Rishi P. Singh, MD)

Retinovascular Diseases

1. Pediatric Imaging - Darius M. Moshfeghi, MD
2. Noteworthy DRCR.net Studies (Protocol T and S) - Baruch D. Kuppermann, MD, PhD
3. Promising Therapies in Development for DME: TIE-2 Activator, Integrin Peptide, and Vascular Adhesion Protein-1 - David S. Boyer, MD
4. Management of Central Serous Chorioretinopathy - Rishi P. Singh, MD

Imaging

1. Widefield Imaging - Rishi P. Singh, MD
2. Future Applications of OCT Imaging (Including Intraoperative OCT) - Justis P. Ehlers, MD
3. Putting It All Together: Imaging Case Discussion - John W. Kitchens, MD

Retina Surgery

1. New Instrumentation for Retina Surgery - John W. Kitchens, MD
2. Face Off – Vitrectomy Devices - Sunil K. Srivastava, MD
3. Future of Retinal Surgery - Peter K. Kaiser, MD
4. Panel Discussion: Vitreoretinal Surgery - Sunil K. Srivastava, MD